| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human Proprotein Convertase 9/PCSK9 Protein, CF |
|---|
| Description | Purity >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. MW (observed): 19 kDa & 66 kDa, reducing conditions. MW (theoretical): 14 kDa & 59 kDa. The Recombinant Human Proprotein Convertase 9/PCSK9 Protein from R&D Systems is derived from NS0. The Recombinant Human Proprotein Convertase 9/PCSK9 Protein has been validated for the following applications: Bioactivity. |
|---|
| Size | 10 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | EC 3.4.21, EC 3.4.21.111, FH3, FH3neural apoptosis regulated convertase 1, HCHOLA3, hypercholesterolemia, autosomal dominant 3, LDLCQ1, NARC-1, NARC-1convertase subtilisin/kexin type 9 preproprotein, NARC1EC 3.4.21.-, Neural apoptosis-regulated convertase 1, PC9, PCSK9, Proprotein convertase 9, proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9 |
|---|
| Gene, Accession, CAS # | PCSK9, Gene ID: 255738, Accession: Q8NBP7 |
|---|
| Catalog # | 3888-SE-010 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Proprotein Convertase 9/PCSK9 Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 25070550 |
|---|
| 产品资料 |
|
|